-
Co-Diagnostics Highlights Global Tuberculosis Initiatives and CoSara Advancements
NASDAQ: $CODX Strategic Focus on Global Health Co-Diagnostics, Inc. recently announced its participation in three major global tuberculosis (TB) events throughout November. These engagements underscore the company’s commitment to addressing one of the world’s most persistent infectious disease challenges through advanced molecular diagnostics. CoSara’s Progress in India A central theme of the announcement is the…